Navigation Links
InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
Date:2/20/2008

HATBORO, Pa., Feb. 20 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that David Gulian, President and CEO, will present at the Growth & Value Investor Conference to be held at the Westin Fort Lauderdale in Florida on February 27-28, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

Mr. Gulian is scheduled to present on Thursday, February 28th followed by a question and answer session. The Growth & Value Investor Conference will be held at the Westin Fort Lauderdale, located at 400 Corporate Drive, Fort Lauderdale, FL. The slide presentation discussed at the conference will be available on InfoLogix's website located at http://www.infologix.com. Electronic versions of the presentation can also be received via email, fax or postal service by contacting InfoLogix's Investor Relations department at the address provided at the end of this release.

InfoLogix's enterprise mobility solutions have been selected by more than 1,400 hospitals and 800 commercial organizations, including 47 of the Fortune 500, to improve productivity, efficiency and revenues. Most recently, InfoLogix has been spotlighted in a FOX Business News feature on medication management and attracted former executives from SAP Americas and GE Healthcare to its team.

About InfoLogix, Inc.

InfoLogix is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, Adventist Health, Swedish Medical Center, and Stanford School of Medicine. Founded in 2001 and headquartered in suburban Philadelphia, PA, InfoLogix has been named the sixth fastest growing new business in the United States for the last three years by Entrepreneur Magazine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information, visit http://www.infologix.com.

About the Growth & Value Investor Conference

The Growth & Value Investor Conference has carefully designated upwards of 30 outstanding publicly traded companies (NYSE, NASDAQ, AMEX, Canadian listed companies and more) and offers you a live, inside look into the core of their strategies, strength of management and the potential for profit. Each corporate presentation is planned to be followed by a question and answer session and one-on-one meeting opportunities are available. There is nothing to buy at the Growth & Value Investor Conference. All are welcome. Attendance is free.

The Growth & Value Investor Conference, "Spring Break for Wall Street," will be held on Wednesday and Thursday, February 27 & 28, 2008. The Complimentary Cocktail Reception will be held from 4:00 PM - 5:00 PM and the Corporate Presentations will follow from 5:00 PM - 9:00 PM. The Growth & Value Investor Conference is presented by LDV Capital Management, a Registered Investment Advisory Firm Licensed with the State of Florida.


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Creator responds to and which He does not. Yisrayl says with so many titles ... the true name, but he says with a little Scripture, backed with a lot of ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
(Date:4/27/2017)... ... 2017 , ... The Incentive Research Foundation is pleased to ... a groundbreaking analysis of how behavioral economics can be applied to the incentive, ... programs, the report highlights proven behavioral economics approaches and the powerful role emotions ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. ... at MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron ... approach to helping organizations maximize the benefits of mobility in their operations securely. ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology: